Skip to main content

Opiate Dependence News (Page 9)

Related terms: Opioid Dependence, Opioid Use Disorder

Suicidal Thoughts, Attempts Common Among Patients Starting Buprenorphine

TUESDAY, July 18, 2023 – There is a high prevalence of suicidal thoughts and attempts among patients with opioid use disorder (OUD) initiating buprenorphine, according to a study published online...

Opioid-Related Adverse Event Risk Increased With Modified-Release Opioids

TUESDAY, July 11, 2023 – For patients undergoing total hip or knee arthroplasty, modified-release opioid use in the acute postoperative period is associated with an increased risk for opioid-related...

First Murder Conviction for Fentanyl Dealer Delivered in California

TUESDAY, July 11, 2023 – A fentanyl dealer has been found guilty of second-degree murder in what authorities believe is the first-ever murder conviction for dealing the dangerous drug. The...

First Murder Conviction for Fentanyl Dealer Delivered in California

TUESDAY, July 11, 2023 – A fentanyl dealer has been found guilty of second-degree murder in what authorities believe is the first-ever murder conviction for dealing the dangerous drug. The...

Deaths Due to Opioid Toxicity Up in U.S. During COVID-19

TUESDAY, July 11, 2023 – Deaths due to opioid toxicity increased during the COVID-19 pandemic, according to a study published online July 7 in JAMA Network Open. Tara Gomes, Ph.D., from St....

Xylazine Increasingly ID'd in Illicitly Manufactured Fentanyl Overdose Deaths

THURSDAY, July 6, 2023 – From 2019 to 2022, there was a considerable increase in illicitly manufactured fentanyl (IMF)-involved overdose deaths with xylazine detected, according to research...

Access to Medical Marijuana Won't Lower Use of Opioid Painkillers: Study

WEDNESDAY, July 5, 2023 – Medical marijuana is touted as a pain reliever, but in U.S. states where it's legal, prescriptions for opioid or non-opioid painkillers haven't decreased, a new study...

Medical Cannabis Laws Seem Not to Have Affected Opioid, Nonopioid Therapy

WEDNESDAY, July 5, 2023 – Medical cannabis laws seem not to have important effects on the receipt of opioid or nonopioid pain treatment, according to a study published online July 4 in the Annals of...

FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies

WEDNESDAY, July 5, 2023 – Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis. On Wednesday...

FDA Approves Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

Plymouth Meeting, Pa. – May 23, 2023—Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (CIII), a...

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Cassipa (buprenorphine and naloxone) Sublingual Film as Maintenance Treatment for Opioid Dependence

September 7, 2018 – The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid...

FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder

November 30, 2017 – The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use...

FDA Medwatch Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

ISSUE: Based on additional review, FDA is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that...

FDA Approves Unique Low Dosage of Zubsolv

Uppsala, Sweden – October 6, 2016 – Orexo AB (publ.) announced today that it has received approval from the US Food and Drug Administration (FDA) of a new unique low dose, 0.7mg/0.18 mg, tablet of Zub...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Opiate Withdrawal, Opiate Dependence - Maintenance, Drug Dependence

Related drug support groups

Suboxone, Subutex, naltrexone, buprenorphine, Vivitrol, Sublocade, buprenorphine / naloxone